Investment
Features
FeesSafety
Academy
More
Pluang+

Bitget confirms cloud database breach exposed only public trade logs, no user data compromised

Market News
20 Oct 2026
Tokenpost
View Source
Neutral
Bitget confirms cloud database breach exposed only public trade logs, no user data compromised

Bitget revealed that a security breach at a cloud database it previously used exposed only public trade logs, with no user data or passwords affected. The data came from TiDB Cloud, operated by PingCAP, where Bitget had stored some trade execution logs visible to all users via its public trade feed. Bitget stopped using this service over two months ago and confirmed that no sensitive or private account information was leaked. This incident highlights the importance of data storage practices but does not compromise user privacy or security.

Bitget's recent disclosure about a TiDB Cloud intrusion provides context for cryptocurrency market activity. For readers following crypto assets, here is Pluang's market snapshot as of Oct 21, 2026 02:31 WIB: out of 50 major cryptocurrencies, 44 rose and 5 fell today. Notable movers include THETA with a 10.25% increase and 100% sell order activity, BAT up 10.08% with 84% sell orders, and EOS rising 8.13%.

More News

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
26 minutes ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
1 hour ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
1 hour ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App